Digital pathology firm Inify Laboratories is collaborating with scientists at the Karolinska Institutet in Stockholm on a project aimed at improving the precision of prostate cancer diagnosis through artificial intelligence (AI)-driven image analysis.
In a statement, Inify said it will work with the multidisciplinary ProMort research team at the Karolinska Institutet on the endeavor. The ProMort program is an international research project working to identify molecular factors and histopathological features associated with prostate cancer death using both standard pathological review and AI, with the goal of developing new prognostic tools for prostate cancer.
Inify's AI development platform will be used to annotate different prostate cancer growth patterns in tumor tissue from diagnostic biopsies, with a focus on cribriform structures, perineural invasion, and reactive stroma. The data will be used to train AI models that can accurately identify and outline these structures to expedite diagnosis.
"A collaboration has great potential to further advance the important work of identifying markers to determine the degree of malignancy in prostate cancer, while also maintaining a high and consistent quality. I am delighted with this partnership and look forward to combining great AI models with talented people," Olof Akre, professor of oncological surgery in the department of molecular medicine and surgery at the Karolinska Institutet, said.
